• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大胆管切除术后原位肝移植治疗肝门部胆管癌。初步长期结果。

Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results.

作者信息

Jonas S, Kling N, Guckelberger O, Keck H, Bechstein W O, Neuhaus P

机构信息

Chirurgische Klinik, Virchow Klinikum der Humboldt Universität, Berlin, Germany.

出版信息

Transpl Int. 1998;11 Suppl 1:S206-8. doi: 10.1007/s001470050462.

DOI:10.1007/s001470050462
PMID:9664980
Abstract

Although the surgical treatment of hilar cholangiocarcinoma represents the only potentially curative option, survival figures remain low over the long term. After hilar and partial hepatic resections for hilar cholangiocarcinoma, loco-regional tumor recurrence appears as the primary site of failure. From April 1992 to April 1996, 14 patients underwent extended bile duct resections. Extended bile duct resections combine total hepatectomy, partial pancreatoduodenectomy, and liver transplantation in an attempt to eradicate the entire biliary tract without dissecting the hepatoduodenal ligament. The postoperative 60-day mortality rate was 14% (n = 2). The rate of curative resections was 93% (13 of 14 extended bile duct resections). One- and 4-year survival rates after curative resections were 56% and 30%, respectively. The rate of curative resections increased by combining total hepatectomy, partial pancreatoduodenectomy, and liver transplantation, i.e., extended bile duct resection. However, survival figures have not improved accordingly. Therefore, this extended surgical procedure has to be implemented with caution and possibly not without modifications (e.g., multimodal treatment).

摘要

尽管肝门部胆管癌的手术治疗是唯一可能治愈的选择,但长期生存率仍然很低。在对肝门部胆管癌进行肝门部及部分肝切除术后,局部区域肿瘤复发是主要的失败部位。1992年4月至1996年4月,14例患者接受了扩大胆管切除术。扩大胆管切除术结合了全肝切除术、部分胰十二指肠切除术和肝移植术,试图在不解剖肝十二指肠韧带的情况下根除整个胆道系统。术后60天死亡率为14%(n = 2)。根治性切除率为93%(14例扩大胆管切除术中的13例)。根治性切除术后1年和4年生存率分别为56%和30%。通过结合全肝切除术、部分胰十二指肠切除术和肝移植术,即扩大胆管切除术,根治性切除率有所提高。然而,生存率并没有相应提高。因此,这种扩大的手术程序必须谨慎实施,可能还需要进行修改(例如多模式治疗)。

相似文献

1
Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results.扩大胆管切除术后原位肝移植治疗肝门部胆管癌。初步长期结果。
Transpl Int. 1998;11 Suppl 1:S206-8. doi: 10.1007/s001470050462.
2
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
3
[Extent of resection in surgical therapy of central bile duct carcinomas].[肝门部胆管癌手术治疗中的切除范围]
Langenbecks Arch Chir Suppl Kongressbd. 1997;114:1075-7.
4
Extended resections for hilar cholangiocarcinoma.肝门部胆管癌的扩大切除术
Ann Surg. 1999 Dec;230(6):808-18; discussion 819. doi: 10.1097/00000658-199912000-00010.
5
Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.肝门部胆管癌行扩大胆管切除和[校正]肝移植:长期结果。
Liver Transpl. 2009 Nov;15(11):1499-507. doi: 10.1002/lt.21887.
6
Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.肝门部胆管扩大切除术的手术步骤及其在肝门部胆管癌中的应用
Hepatogastroenterology. 2002 Mar-Apr;49(44):300-5.
7
Aggressive surgical treatment of hilar cholangiocarcinoma.肝门部胆管癌的积极手术治疗
J Hepatobiliary Pancreat Surg. 1998;5(1):52-61. doi: 10.1007/pl00009951.
8
One hundred and eleven liver resections for hilar bile duct cancer.针对肝门部胆管癌进行的111例肝切除术。
J Hepatobiliary Pancreat Surg. 2000;7(2):135-41. doi: 10.1007/s005340050167.
9
Surgery for hilar cholangiocarcinoma--the German experience.肝门部胆管癌的手术治疗——德国的经验
J Hepatobiliary Pancreat Surg. 2000;7(2):142-7. doi: 10.1007/s005340050168.
10
Extended right hepatectomy for hilar cholangiocarcinoma with resection of the left hepatic duct prior to hepatic resection.肝门部胆管癌扩大右半肝切除术,术中在肝切除术前先行左肝管切除。
J Surg Oncol. 2006 Jan 1;93(1):72-5. doi: 10.1002/jso.20401.

引用本文的文献

1
Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001).肝门部胆管癌肝移植术后吉西他滨辅助化疗的可行性和疗效——一项多中心、随机、对照试验(产品001)
Front Oncol. 2022 Oct 6;12:910871. doi: 10.3389/fonc.2022.910871. eCollection 2022.
2
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?肝门部胆管癌的外科治疗:过去十年有何变化?
World J Surg. 2015 Nov;39(11):2748-56. doi: 10.1007/s00268-015-3125-2.
3
[Liver transplantation for hilar cholangiocarcinoma].
[肝门部胆管癌的肝移植]
Chirurg. 2012 Mar;83(3):229-37. doi: 10.1007/s00104-011-2178-5.
4
The role of liver transplantation in the treatment of hilar cholangiocarcinoma.肝移植在肝门部胆管癌治疗中的作用。
HPB (Oxford). 2005;7(4):268-72. doi: 10.1080/13651820500372780.
5
Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases.肝外胆管切除联合肝切除治疗肝门部胆管癌:42例报告
J Gastrointest Surg. 2004 Sep-Oct;8(6):686-94. doi: 10.1016/j.gassur.2004.04.006.
6
Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.肝门部胆管癌切除术:关键预后因素及肿瘤硬化的影响
World J Surg. 2003 Jun;27(6):680-4. doi: 10.1007/s00268-003-6656-x. Epub 2003 May 13.
7
Photodynamic therapy in the biliary tract.胆道中的光动力疗法。
Curr Gastroenterol Rep. 2001 Apr;3(2):154-9. doi: 10.1007/s11894-001-0013-8.